Hepatitis B viruses (HBV) and related viruses, classified in the Hepadnaviridae family, are found in a wide variety of mammals and birds. Although the chimpanzee has been the primary experimental model of HBV infection, this species has not been considered a natural host for the virus. Retrospective analysis of 13 predominantly wild-caught chimpanzees with chronic HBV infection identified a unique chimpanzee HBV strain in 11 animals. Nucleotide and derived amino acid analysis of the complete HBV genome and the gene coding for the hepatitis B surface antigen (S gene) identified sequence patterns that could be used to reliably identify chimpanzee HBV. This analysis indicated that chimpanzee HBV is distinct from known human HBV genotypes and is closely related to HBVs previously isolated from a chimpanzee, gibbons, gorillas, and orangutans.
H
epatitis B virus (HBV) produces a chronic infection that affects a substantial proportion of the world's population and results in death from chronic liver disease and hepatocellular carcinoma. HBV is the prototype of the Hepadnaviridae family, which includes mammalian viruses (genus Orthohepadnavirus), such as human HBV, woodchuck hepatitis virus (1), Beechey ground squirrel hepatitis virus (2) , and Arctic ground squirrel hepatitis virus (3) and avian viruses (genus Avihepadnavirus) (4, 5) . Soon after characterization of human HBV, chimpanzees were shown to be susceptible to experimental HBV infection (6) . In addition, testing of wild-caught chimpanzees revealed that 3-6% were positive for hepatitis B surface antigen (HBsAg) (7) (8) (9) (10) , a marker of chronic HBV infection, and as many as 50% of older animals were positive for antibody to HBsAg (anti-HBs), a marker of resolved infection (11) . However, these HBV infections were not considered indigenous to chimpanzees but were thought to be the result of the practice in Africa of injecting young, wild-caught animals with human serum to improve survival during transit and confinement. The human serum used for this practice was thought to be the source of the infection because Ͼ10% of persons in Africa have chronic HBV infection (12) .
The subsequent isolation of unique HBV genome sequences from selected non-human primates with chronic HBV infections (13) (14) (15) (16) suggests the existence of HBV strains indigenous to these animals. To confirm the existence of a chimpanzee-specific strain of HBV, we examined the genetic relatedness of isolates obtained from 13 chimpanzees with chronic infection, the majority of which were wild-caught.
Materials and Methods
Chronic Carrier Chimpanzees. The following wild-caught animals were included in the study (identification number, sex, estimated date of birth, institution): NIH28, male (M), unknown, National Institutes of Health (NIH); NIH29, female (F), 1970, NIH;  NIH39, F, 1968, NIH; NIH40, M, 1969, NIH; NIH44, ?, unknown, NIH; NIH56, M, 1974, NIH; NIH57, F, 1973, NIH;  NIH814, 1970, F, NIH; NIH821, M, 1969, NIH; CH109, DNA Extraction, Amplification, and Sequence Determination and Analysis. HBV DNA was extracted from serum specimens by using a modification of the Master Pure procedure (Epicentre Technologies, Madison, WI) in which 50 l of serum was mixed with an equal amount of 2ϫ T & C lysis solution containing 333 g͞ml proteinase K and incubated at 65°C for 1 hr. After proteinase K digestion, samples were placed on ice for 5 min, 50 l of MPC protein precipitation reagent was added, the mixture was vortexed and centrifuged at 10,000 ϫ g for 10 min at 4°C, and the supernatant was transferred to a new Eppendorf tube. DNA was precipitated in 500 l of ice-cold isopropanol by centrifugation at 10,000 ϫ g for 10 min at 4°C. The DNA pellet was rinsed twice with 500 l of ice-cold 75% ethanol, was air-dried, and was resuspended in 20 l of water.
The complete HBV genome from CH109 and CH926 was PCR amplified with eight primer pairs selected from conserved genome regions such that the resulting fragments overlapped adjacent amplicons by at least two-thirds of their length. The primers (shown below from 5Ј to 3Ј direction) were HBV2853P TCACCATAT-TCTTGGGAACA; HBV2853N TGTTCCCAAGAATATG-GTGA; HBV58P CCTGCTGGTGGCTCCAGTTC; HBV58N GAACTGGAGCCACCAGCAGG; HBV409P CATCCTGCT-GCTATGCCTCATCT; HBV409N AGATGAGGCATAGCAG-CAGGATG; HBV730P AGTGCCATTTGTTCAGTGGTTCG; HBV730N AGTGCCATTTGTTCAGTGGTTCG; HBV 1101P CTCGCCAACTTACAAGGCCTTTC; HBV1101N GAAAG-GCCTTGTAAGTTGGCGAG; HBV1450P TACGTCCCGTC-GGCGCTGAATC; HBV1450N GATTCAGCGCCGACGG-GACGTA; HBV1860P ACTGTTCAAGCCTCCAAGCTG; HBV1860N CAGCTTGGAGGCTTGAACAGT; HBV2440P GCCGCGTCGCAGAAGATCTCAA; HBV2440N TTGAGAT-CTTCTGCGACGCGGC. The entire 20 l of resuspended HBV viral DNA solution was added to a mixture containing 20 l of 5ϫ Invitrogen Buffer, 4 l of 10 mM dNTPs (Invitrogen), 1 l of 10 uM positive sense primer (HBVxxxxP), 1 l of 10 M negative sense primer (HBVxxxxN), 1.6 l of TaqStart Dilution Buffer (CLON-TECH), 1.6 l of Taq polymerase antibody (CLONTECH), 2 units of Taq polymerase (Boehringer Mannheim), and 51.6 l of water. PCR amplification was performed by using a modification of a previously described method (17) with cycling conditions as follows: denaturation at 94°C for 3 min; 45 cycles at 94°C for 45 sec and 55°C for 45 sec; ramping to 72°C within 1 min and extension at 72°C for 3 min; and a final extension cycle at 72°C for 7 min. PCR-amplified products were examined by agarose gel electrophoresis and then were purified by using a QIAquick Purification Kit (Qiagen, Valencia, CA). Cycle sequencing was performed by using dRho-damine terminators, and the products were electrophoresed on a Perkin-Elmer 377 sequencer (PE Biosystems, Foster City, CA). Archived serum specimens from chimpanzees NIH28, NIH29, NIH39, NIH40, NIH44, NIH56, NIH57, NIH800, NIH814, NIH821, and NIN904 were used to amplify and sequence the S gene as described above by using primers HBV2853P or HBV58P and 1101N.
A consensus nucleic acid and amino acid sequence was generated for each of the six human HBV genotypes by using the GCG PRETTY program (Genetics Computer Group, Madison, WI). These consensus sequences, designated genotype a (gntya) through gntyf, were derived by using the individual sequences ( Fig. 1) , which are representative of complete genome sequences available in GenBank. In addition, a consensus gibbon HBV sequence was derived by the same approach.
Sequence analysis and alignments were performed by using the PILEUP program within the University of Wisconsin GCG SEQUENCE ANALYSIS computer software package (Genetics Computer Group). Genetic distances were calculated by using the Jukes and Cantor correction within DNADIST of PHYLIP 3.5C (18) , and the results are graphically illustrated as a neighborjoining tree. Boot strap values representing 1,000 replicates were determined by using SEQBOOT, DNADIST, NEIGHBOR, and CON-SENSE in the PHYLIP package.
Results
The complete genome was sequenced from two animals, and the gene coding for HBsAg was sequenced from 11 additional animals.
All animals were found to be HBsAg positive upon arrival at either the Centers for Disease Control and Prevention or the National Institutes of Health (NIH), where they were used for experimental transmission of infections with hepatitis viruses. The serum samples tested in this study were obtained before experimental inoculation of material containing hepatitis viruses. Although the precise date and place of birth for most of these animals were unknown, all but two were known to have been captured in Africa as infants before chimpanzees were listed as a threatened species. Two chimpanzees (CH800 and CH904) were born and reared in captivity; their father was HBsAg-positive, but the HBsAg status of the mother was unknown.
The complete HBV genome was amplified and sequenced from chimpanzees CH109 and CH926. The complete HBV genome from each animal was composed of 3,182 nucleotides and had a genetic organization identical to human HBV, with four ORFs encoding the S, X, C, and P genes and a characteristic 11-bp direct repeat motif located at positions 1827-1837 (DR1) and 1593-1603 (DR2). These two isolates had a 93.7% identity with each other and a 93-98% identity with HBV from a wild-caught chimpanzee at the London zoo (D00220, Table 1 ). Chimpanzee HBV isolates had a 87.5-91.2% nucleotide sequence identity with consensus sequences of each of the six human HBV genotypes (19, 20) ; this degree of variation is similar to that observed between the human HBV genotypes ( Table 1 ).
The phylogenetic relationship of chimpanzee HBV to the six respective human HBV genotypes and HBV isolates from other non-human primates is shown in Fig. 1 A. Each non-human primate HBV clusters on a distinct phylogenetic branch, and, with the exception of the wooly monkey isolate, all of the non-human primate isolates originate from a node that is distinct from any human HBV genotype (Fig. 1 A) .
When the derived amino acid sequence from the three complete chimpanzee genomes were compared with each of the human HBV genotypes and the other non-human primate genome sequences, certain patterns appeared to identify certain non-human primate HBVs (Figs. 2 and 3 ). These included (i) a glutamic acid at position 16 of the preS region in chimpanzee, gorilla, and gibbon isolates (Fig. 2, preS) ; (ii) three amino acid changes (L 133 -I͞L͞Y 134 and A 177 ) in the S gene of the chimpanzee, gorilla, and gibbon HBV isolates (Fig. 2, HBsAg) ; (iii) a gluatmine at position 113 coding for hepatitis B core antigen of the chimpanzee and gorilla HBVs that replaced a leucine in human HBV (Fig. 2, Core) ; and (iv) an 11-amino acid deletion in the polymerase (P) gene in the non-human primate isolates that was also found in human genotype D (Fig. 3) . In addition, a precore stop codon (TTG 3 TAG) at position 28 (Fig. 2, Core) was found in two chimpanzees; a leucine was present in the remaining non-human primate isolates, in contrast to the tryptophan found in all human isolates. Three amino acid changes in the X gene product of chimpanzees (T 11 , K 107 , T 110 ; Fig. 2) were found, two of which were also found in the gorilla sequence (K 107 , T 110 ; Fig. 2 ) whereas multiple changes within the preS1 and preS2 overlap region (data not shown) were also present.
Nucleotide sequences were obtained from the HBsAg coding region (S gene) on an additional 11 chimpanzees with chronic HBV infection. The isolates from nine animals were closely related to those of CH109, CH926, and D00220 (Fig. 1B) whereas two chimpanzees (Fig. 1B, NIH28 and NIH44) had isolates related to human HBV genotypes A and C, respectively. The derived amino acid sequences indicated that the chimpanzee isolates would be classified as subtype adw (21) whereas the gibbon and woolly monkey isolates would be classified as subtype ayw. The translated amino acids from the S gene sequences from the additional chimpanzee HBV strains also contained the three amino acid substitutions (L 133 -I͞L 134 and A 177 ) found in the full-length sequences (Fig. 2) .
Comparison of the branching order of non-human primate strains and human HBV genotypes by using the complete genome and the S gene produced different phylogenetic pictures ( Fig. 1 A and B) . In the S gene analysis, the gibbon HBV does not cluster with the other non-human primate strains whereas comparison of the complete genome demonstrated the genetic relatedness of the gibbon isolate to the other non-human primate isolates. These data indicate that, although the S gene region may be adequate for genotype assignment (18) , the complete HBV genome provides additional information necessary to derive conclusions concerning phylogenetic relatedness. In light of this observation, a complete sequence of HBV from orangutans with chronic HBV infection (16) would probably cluster with the gibbon, chimpanzee, and gorilla HBV sequences.
Discussion
The HBVs isolated from 11 of the 13 chimpanzees with chronic infection appear to be genetically distinct from known human HBV genotypes and appear to represent a virus that produces an infection indigenous to chimpanzees. The two additional animals with chronic HBV infection had human HBV isolates, a finding that could be explained by the practice of injecting wild-caught infant animals with human serum. When compared with HBVs isolated from other primates, the chimpanzee HBV has unique nucleotide and amino acid differences throughout the entire genome and the S gene that allow the rapid and precise identification of this strain. In addition, our analysis confirms the existence of indigenous non-human primate HBV strains in both Old World great apes and New World monkeys.
The phylogenetic evolution of the non-human primate HBVs with respect to human HBV is not clear. The woolly monkey HBV and human genotype F appear to be related with respect to their phylogenetic and geographic (South American) proximity. However, although such phylogenetic patterns and geographic proximity may suggest possible zoonotic transmission of HBVs, a number of biologic and epidemiologic inconsistencies argue for independent evolution within various geographically separated species or populations. These inconsistencies include the following: (i) the gibbon and chimpanzee nucleic acid sequences are more closely related to each other than to human genotypes, and these two types of great apes are widely separated geographically (Africa and Asia); (ii) the human genotypes found in Africa and Asia differ-Asia is predominantly B and C, and Africa is predominantly A and E; and (iii) the possible modes of virus transmission between non-human primates and humans are unclear because blood-borne viruses are primarily transmitted by sex, birth, or the direct inoculation of blood.
The extent to which chronic HBV infection occurs in free living non-human primate populations is unknown. However, it is unlikely that the presence of HBVs indigenous to non-human primates would have important public health implications. Because gibbon and woolly monkey HBV strains have been shown to produce infection in chimpanzees (15, 22) , and human HBV causes disease in chimpanzees, the potential for zoonotic disease transmission exists where blood or body fluid exposure is common. Such scenarios could include chronically infected animals kept as family pets, close contact with caretakers, or in situations in which chimpanzees are slaughtered and used as bushmeat. Human HBV infection can be prevented by immunization with hepatitis B vaccine, which contains HBsAg to induce protective immunity through the amino acids that comprise the a determinant (underlined in Fig. 2 ). Among the Old World non-human primate HBVs, all contain the immunodominant glycine at position 145 of the a determinant, and other amino acid changes are limited, which indicates that available hepatitis B vaccines would prevent infection in the unlikely event of exposure to non-human primate HBVs.
Note Added in Proof. Similar sequence information has been obtained in another study (S. Mishiro, personal communication) and has been deposited under GenBank accession numbers AB032431-AB032433. For the purposes of HBV nomenclature, we have proposed that the chimpanzee HBV be abbreviated as ChHBV. Fig. 3 . Comparison of the polymerase coding regions with translated amino acid sequence differences and deletion. Sequences shown are described in the legend to Fig. 2. A comparison of the complete amino acid sequences is published as supplemental data on the PNAS web site, www.pnas.org.
